Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$493,989
-$3,351,926 QoQ
Shares Held
3,910
-85.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,376
of 2,266 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. GILD ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
|
4,465 | $964,707 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,989 | 3,910 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,845,915 | 27,595 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,435,615 | 27,991 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,145,407 | 28,337 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,694,631 | 33,324 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,673,671 | 32,786 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,807,493 | 30,394 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,497,425 | 29,788 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,075,795 | 30,255 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,162,413 | 29,521 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,570,042 | 31,725 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,920,862 | 25,632 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,082,277 | 27,018 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,334,858 | 28,141 | Shares | Sole | 2023-05-08 | |
| 2021-12-31 | $724,647 | 9,980 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $748,093 | 10,710 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $726,541 | 10,551 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $694,772 | 10,750 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $690,963 | 11,860 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $803,081 | 12,709 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $993,372 | 12,911 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $978,159 | 13,084 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||